Analyst Price Targets — ADVM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 29, 2025 12:51 pm | — | Mizuho Securities | $5.50 | $4.22 | TheFly | Adverum Biotechnologies price target lowered to $5.50 from $12 at Mizuho |
| October 28, 2025 12:59 pm | — | RBC Capital | $4.00 | $4.24 | TheFly | Adverum Biotechnologies price target raised to $4 from $3 at RBC Capital |
| October 24, 2025 5:52 pm | Joon Lee | Truist Financial | $5.00 | $4.07 | TheFly | Adverum Biotechnologies downgraded to Hold from Buy at Truist |
| November 5, 2024 11:57 am | Luca Issi | RBC Capital | $10.00 | $7.72 | StreetInsider | Adverum Biotechnologies (ADVM) PT Lowered to $10 at RBC Capital |
| October 14, 2024 7:55 am | Francois Brisebois | Oppenheimer | $28.00 | $7.81 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Adverum Biotechnologies (ADVM) |
| September 20, 2024 6:46 am | Graig Suvannavejh | Mizuho Securities | $20.00 | $7.50 | StreetInsider | Mizuho Reiterates Outperform Rating on Adverum Biotechnologies (ADVM) |
| August 13, 2024 9:45 am | Luca Issi | RBC Capital | $12.00 | $6.64 | TheFly | Adverum Biotechnologies price target lowered to $12 from $15 at RBC Capital |
| November 11, 2022 8:23 am | — | Chardan Capital | $2.00 | $0.71 | Benzinga | Chardan Capital Maintains Neutral on Adverum Biotechnologies, Lowers Price Target to $2 |
Latest News for ADVM
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $10.50 Consensus Target Price from Analysts
Adverum Biotechnologies, Inc. (NASDAQ: ADVM - Get Free Report) has been given a consensus recommendation of "Hold" by the six analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ADVM.
U.S. House Trading
No House trades found for ADVM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.